NAFLD, a prevalent liver condition linked to metabolic syndrome, poses a significant health concern globally. Our study delved into the fascinating interplay between gut bacteria and NAFLD development. Compelling evidence highlights the role of gut bacteria in obesity, internal ethanol production, inflammation, and choline metabolism. These findings pave the way for targeted interventions to effectively manage NAFLD and its complications.

With 11.2% of the global population affected by IBS, finding effective treatments is crucial. Our comprehensive meta-analysis examined various probiotic types, doses, and treatment durations for IBS patients. The results unveiled the power of probiotics as a pharmacological therapy, particularly when single probiotics are administered at a low dose and for a short duration. These findings empower individuals seeking effective solutions to manage IBS symptoms and improve their overall quality of life.